文献速递乳腺MR

有乳腺癌个人史女性的简化乳腺MRI筛查:与全方案乳腺MRI的比较

Abbreviated Screening MRI for Women with a History of Breast Cancer: Comparison with Full-Protocol Breast MRI.
PubMed 文献 · Radiology · 2022-06-14

本研究为单中心回顾性研究,采用倾向性评分匹配比较有乳腺癌个人史女性简化乳腺MRI与全方案MRI的筛查性能,每组各726例。简化MRI敏感度与全方案MRI相当,特异度更高,BI-RADS 3类短期随访率低于全方案MRI的一半。

要点

  • 简化MRI与全方案MRI敏感度相当:15/15(100%)vs 9/13(69%),P=0.17。
  • 简化MRI特异度高于全方案MRI:660/711(93%)vs 612/713(86%),P<0.001。
  • 简化MRI的BI-RADS 3类短期随访率低于全方案MRI的一半:5% vs 12%,P<0.001。

核心结论

  • 在有乳腺癌个人史女性中,简化乳腺MRI筛查的敏感度与全方案MRI相当,特异度优于全方案MRI。

研究设计与样本

  • 单中心回顾性研究,采用倾向性评分匹配,简化MRI组与全方案MRI组各726例,比较两组筛查性能。

诊断标准与关键数值

  • 简化MRI敏感度15/15(100%;95%CI:78,100),全方案MRI敏感度9/13(69%;95%CI:39,91),P=0.17。
  • 简化MRI特异度660/711(93%;95%CI:91,95),全方案MRI特异度612/713(86%;95%CI:83,88),P<0.001。
  • 简化MRI癌症检出率21/1000次检查,全方案MRI为12/1000次检查,两组相当(P<0.05)。
  • 简化MRI间期癌率0/1000次检查,全方案MRI为5/1000次检查,两组相当(P<0.05)。
  • 简化MRI活检阳性预测值(PPV3)61%(14/23次检查),全方案MRI为41%(9/22次检查),两组相当(P<0.05)。

临床应用与阅片要点

  • 简化MRI的BI-RADS 3类短期随访率为5%(36/726次检查),低于全方案MRI的12%(84/726次检查),P<0.001。
  • 简化MRI检出的15例癌症中,93%(14/15)为淋巴结阴性T1期浸润癌(n=6)或导管原位癌(n=8)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Few studies have compared abbreviated breast MRI with full-protocol MRI in women with a personal history of breast cancer (PHBC), and they have not adjusted for confounding variables. Purpose To compare abbreviated breast MRI with full-protocol MRI in women with PHBC by using propensity score matching to adjust for confounding variables. Materials and Methods In this single-center retrospective study, women with PHBC who underwent full-protocol MRI (January 2008-August 2017) or abbreviated MRI (September 2017-April 2019) were identified. With use of a propensity score-matched cohort, screening performances were compared between the two MRI groups with the McNemar test or a propensity score-adjusted generalized estimating equation. The coprimary analyses were sensitivity and specificity. The secondary analyses were the cancer detection rate, interval cancer rate, positive predictive value for biopsies performed (PPV3), and Breast Imaging Reporting and Data System (BI-RADS) category 3 short-term follow-up rate. Results There were 726 women allocated to each MRI group (mean age ± SD, 50 years ± 8 for both groups). Abbreviated MRI and full-protocol MRI showed comparable sensitivity (15 of 15 cancers [100%; 95% CI: 78, 100] vs nine of 13 cancers [69%; 95% CI: 39, 91], respectively; P = .17). Abbreviated MRI showed higher specificity than full-protocol MRI (660 of 711 examinations [93%; 95% CI: 91, 95] vs 612 of 713 examinations [86%; 95% CI: 83, 88], respectively; P < .001). The cancer detection rate (21 vs 12 per 1000 examinations), interval cancer rate (0 vs five per 1000 examinations), and PPV3 (61% [14 of 23 examinations] vs 41% [nine of 22 examinations]) were comparable (all P < .05). The BI-RADS category 3 short-term follow-up rate of abbreviated MRI was less than half that of full-protocol MRI (5% [36 of 726 examinations] vs 12% [84 of 726 examinations], respectively; P < .001). Ninety-three percent (14 of 15) of cancers detected at abbreviated MRI were node-negative T1-invasive cancers (n = 6) or ductal carcinoma in situ (n = 8). Conclusion Abbreviated breast MRI showed comparable sensitivity and superior specificity to full-protocol MRI in breast cancer detection in women with a personal history of breast cancer. © RSNA, 2022 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Kim, Cho, Hong, et al. Abbreviated Screening MRI for Women with a History of Breast Cancer: Comparison with Full-Protocol Breast MRI. Radiology. 2022. PMID: 35699580. doi:10.1148/radiol.213310

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。